Medical Developments International

Medical Developments International FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Medical Developments International (MVP.AX) as of Oct 8, 2026 is 841.69 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -517.02 % — a change of -262.80% (higher).

FCF Conversion

841.69 %

YoY

-262.80%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Medical Developments International is 2026 841.69 % . FCF Conversion Rate (FCF/EBITDA) of Medical Developments International was 2025 -517.02 % . It decreases by -262.80% higher compared to the previous year.

The Medical Developments International FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
1,905.97 AUD
Jan 1, 2020
-2,303.17 AUD
Jan 1, 2021
122.31 AUD
Jan 1, 2022
128.44 AUD
Jan 1, 2023
430.74 AUD
Jan 1, 2024
34.03 AUD
Jan 1, 2025
-517.02 AUD
Jan 1, 2026
841.69 AUD
The Medical Developments International FCF Conversion history
YEARFCF ConversionYoY
841.69 %-262.80%
-517.02 %-1,619.37%
34.03 %-92.10%
430.74 %+235.35%
128.44 %+5.02%
122.31 %-105.31%
-2,303.17 %-220.84%
1,905.97 %-1,828.18%
-110.29 %+486.91%
-18.79 %-102.77%
678.52 %+269.99%
183.39 %+64.92%
111.20 %—
Access this data via the Eulerpool API
Get Free API Key

Medical Developments International Stock analysis

What does Medical Developments International do? Medical Developments International Ltd is an Australian company specializing in the development and production of medical devices and products. The company was founded in 1971 by renowned researcher and entrepreneur Mark Sullivan and has since received numerous awards and accolades. The company's business model is based on the manufacture of emergency medical devices and products of the highest quality and effectiveness. It has three main business segments: Pharmaceuticals, Medical devices, and Animal health. Medical Developments International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medical Developments International stock

FCF Conversion Rate (FCF/EBITDA) of Medical Developments International is 841.69 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Medical Developments International changed from -517.02 % to 841.69 %, representing a -262.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Medical Developments International since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Medical Developments International with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Medical Developments International

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Medical Developments International